• Human APIs PowderRespiratory Drugs Raw Material Antiviral Antibacterial Antipyretic Analgesics Antihistamine Drugs Antineoplastic Cosmetic Raw Material
  • Pharmaceutical IntermediatesPharmaceutical intermediates Nutritional Supplements Pharmaceutical raw materials
  • OEM & ODMCapsule Softgel Capsule Gummies Drop & drinks Tables
  • Veterinary raw materialsAntibacterial anti-inflammatory Respiratory Drugs Anthelmintics Antiviral drugs Feed additives
  • About UsCompany profileQualificationQuality AssuranceService teamFactory TourR&D Center
  • Pharmaceutical intermediates Raw material powder Exemestane

    • Pharmaceutical intermediates Raw material powder Exemestane
    • Pharmaceutical intermediates Raw material powder Exemestane storehouse
    • Pharmaceutical intermediates Raw material powder Exemestane quality testing
    • Pharmaceutical intermediates Raw material powder Exemestane quality testing
    • Pharmaceutical intermediates Raw material powder Exemestane certificate

    Product Overview:

    Exemestane is an irreversible steroid aromatase inhibitor, similar in structure to its substrate natural androstenedione. Estrogen deprivation by inhibiting aromatase is an effective and alternative treatment for hormone-dependent breast cancer in postmenopausal women with advanced breast cancer that has not progressed after tamoxifen therapy in natural or artificial postmenopausal women.

    Pharmaceutical intermediates Raw material powder Exemestane Attributes

    Exemestane Raw material powder

    CAS:107868-30-4

    MF:C20H24O2

    Exemestane

    MW:296.4

    EINECS:643-090-2

    Specification: 99% min Exemestane powder

    Sample:Exemestane powder

    Packaging:1kg/bag, 25kg/drum

    Brand: Henrikang

    Appearance: white

    Storage: Cool Dry Place

    Shelf Life: 2 Years

    Test Method: HPLC

    Pharmaceutical intermediates Raw material powder Exemestane Details

    Exemestane Powder Usage and Synthesis.

    Exemestane is a steroid aromatase inactivator, whose structure is similar to the natural substrate of aromatase, androstenedione, and is the pseudo-substrate of aromatase. Since estrogen in postmenopausal women is mainly produced by the conversion of androgens (produced by the adrenal cortex) in the peripheral tissues under the action of aromatase, this product inactivates it by irreversibly binding to the active site of the aromatase, thus significantly reducing the level of estrogen in the blood circulation of postmenopausal women.

    This product has no significant effect on the biosynthesis of adrenal corticosteroids, even if the concentration is 600 times higher than that of inhibiting aromatase, it has no significant effect on other enzymes in the corticosteroid production pathway. The oral absorption of this product is rapid, the absorption is affected by food, and the oral bioavailability is 42%. The absorption rate of postmenopausal women was higher than that of healthy subjects. The peak blood concentration was reached 2 ~ 4 hours after oral administration of this product, and the average peak time was 1.2 hours, which was shorter than that of healthy subjects (2.9 hours). It mainly binds to α1-acid glycoprotein and protein, and the total protein binding rate is 90%. The metabolite is inactive 17-hydrogen exemestane with a clearance half-life of 24 hours. It is mainly excreted in urine or feces, each accounting for 42% of the dose.

    Exemestane powder

    Uses of Exemestane.

    The pharmaceutical raw material is an irreversible steroid aromatase inactivator, which can inhibit estrogen synthesis and reduce the level of estrogen in blood circulation. It is suitable for postmenopausal advanced breast cancer patients who progress after tamoxifen treatment. Second generation aromatase inhibitors are used for the treatment of metastatic breast cancer and as adjuvant therapy for early breast cancer.

    Exemestane

    In vitro study of Exemestane.

    Product Method of Bulk Exemestane Powder.

    Androstene-4-ene-3, 17-dione and triethyl orthoformate were dissolved in tetrahydrofuran and anhydrous ethanol, reacted in the presence of p-toluenesulfonic acid, and then added to n-methylaniline and formaldehyde solutions to continue the reaction. The Mannich reaction product was dissolved in benzoic acid and anhydrous dichethanes, and exemestane was obtained under the action of DDQ with a total yield of 45%.

    Our advantage
    Our Factory
    Shipping
    Tel: 86-29-89601602
    WhatsApp: 8615091775531
    WeChat: 15091775531
    E-mail: sales21@interlgroup.com
    Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
    ©2023 Xi'an Henrikang Biotech Co., Ltd.,